Lataa...
Comparative research on (99m)Tc-Rituximab and (99m)Tc-sulfur colloid in sentinel lymph node imaging of breast cancer
BACKGROUND: (99m)Tc-Rituximab is a new specific radiopharmaceutical that binds to the CD20 receptor which is highly expressed on the surface of B cells. We conducted a study in which (99m)Tc-Rituximab was compared with filtered (99m)Tc-sulfur colloid (fTcSC) for sentinel lymph node (SLN) detection i...
Tallennettuna:
| Julkaisussa: | BMC Cancer |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6794795/ https://ncbi.nlm.nih.gov/pubmed/31615471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6197-9 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|